Cardiovascular risk stratification in asymptomatic individuals in Bitola, North Macedonia by using High sensitive Troponin I Assay

[eng] Objectives: The aim of our prospective cohort study in Macedonia was to evaluate the distribution of hs-cTnI concentrations in health individuals to stratified cardiovascular risk. Background: The latest generations of hs-cTnI could be used for the stratification of cardiovas...

Descripción completa

Detalles Bibliográficos
Autores: Ilkovska, Biljana, Trifunova, Bisera Kotevska, Avramovski, Petar
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Universidad de las Islas Baleares
Repositorio:Biblioteca Digital de les Illes Balears
OAI Identifier:medicinaBalear:AJHS_Medicina_Balear_2023v38n2p104
Acceso en línea:http://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n2p1/04.dir/AJHS_Medicina_Balear_2023v38n2p104.pdf
http://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n2p104
Access Level:acceso abierto
Palabra clave:Cardiovascular system -- Diseases
Health Sciences
Descripción
Sumario:[eng] Objectives: The aim of our prospective cohort study in Macedonia was to evaluate the distribution of hs-cTnI concentrations in health individuals to stratified cardiovascular risk. Background: The latest generations of hs-cTnI could be used for the stratification of cardiovascular risk in the general population, using values within the normal range. Methods: Study was performed from one year period in 2021 year. We measured hs-cTnI concentrations in 1201 participants 690 males and 511 females by using Abbott Architect analyzer. Results: We found that elevated risk for cardiovascular event is higher in males compared to females, also we confirm that risk of cardiovascular events increase significantly with age in both sexes, but is predominant in males. Conclusion: The hs-cTnI assay provides detection of troponin in a significant proportion of asymptomatic individuals. Hs-cTnI allows us to act preventively in patients at increased risk by including statin therapy, weight regulation or lifestyle changes, intensifying physical activity, while its values are parallel to the modification of cardiovascular risk. Patients should be informed that there is a possibility of cardiovascular risk assessment and more massive hs-cTnI examination.